(Q43833451)

English

Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis

scientific article published in January 2002

Statements

Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis (English)
Christine Beham-Schmid
Ute Apfelbeck
Oleksiy Tsybrovsky
Gerald Höfler
Oskar A Haas
Werner Linkesch
1 January 2002
381-383

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit